BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

197 related articles for article (PubMed ID: 35431891)

  • 1. Reduction in Volume of Nucleus Basalis of Meynert Is Specific to Parkinson's Disease and Progressive Supranuclear Palsy but Not to Multiple System Atrophy.
    Rogozinski S; Klietz M; Respondek G; Oertel WH; Grothe MJ; Pereira JB; Höglinger GU
    Front Aging Neurosci; 2022; 14():851788. PubMed ID: 35431891
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Diffusion-weighted magnetic resonance imaging differentiates Parkinsonian variant of multiple-system atrophy from progressive supranuclear palsy.
    Paviour DC; Thornton JS; Lees AJ; Jäger HR
    Mov Disord; 2007 Jan; 22(1):68-74. PubMed ID: 17089396
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Whole-Brain Atrophy Differences between Progressive Supranuclear Palsy and Idiopathic Parkinson's Disease.
    Guevara C; Bulatova K; Barker GJ; Gonzalez G; Crossley NA; Kempton MJ
    Front Aging Neurosci; 2016; 8():218. PubMed ID: 27679572
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Radiomics on routine T1-weighted MRI can delineate Parkinson's disease from multiple system atrophy and progressive supranuclear palsy.
    Tupe-Waghmare P; Rajan A; Prasad S; Saini J; Pal PK; Ingalhalikar M
    Eur Radiol; 2021 Nov; 31(11):8218-8227. PubMed ID: 33945022
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Montreal Cognitive Assessment (MoCA) and Mini-Mental State Examination (MMSE) performance in progressive supranuclear palsy and multiple system atrophy.
    Fiorenzato E; Weis L; Falup-Pecurariu C; Diaconu S; Siri C; Reali E; Pezzoli G; Bisiacchi P; Antonini A; Biundo R
    J Neural Transm (Vienna); 2016 Dec; 123(12):1435-1442. PubMed ID: 27334897
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Meynert nucleus-related cortical thinning in Parkinson's disease with mild cognitive impairment.
    Rong S; Li Y; Li B; Nie K; Zhang P; Cai T; Mei M; Wang L; Zhang Y
    Quant Imaging Med Surg; 2021 Apr; 11(4):1554-1566. PubMed ID: 33816191
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Regional brain volumes distinguish PSP, MSA-P, and PD: MRI-based clinico-radiological correlations.
    Paviour DC; Price SL; Jahanshahi M; Lees AJ; Fox NC
    Mov Disord; 2006 Jul; 21(7):989-96. PubMed ID: 16602104
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Nucleus Basalis of Meynert Degeneration Predicts Cognitive Decline in Corticobasal Syndrome.
    Urso D; Nigro S; Tafuri B; De Blasi R; Pereira JB; Logroscino G;
    Biol Psychiatry; 2024 Jun; 95(11):1048-1054. PubMed ID: 38309321
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Apraxia in Parkinson's disease, progressive supranuclear palsy, multiple system atrophy and neuroleptic-induced parkinsonism.
    Leiguarda RC; Pramstaller PP; Merello M; Starkstein S; Lees AJ; Marsden CD
    Brain; 1997 Jan; 120 ( Pt 1)():75-90. PubMed ID: 9055799
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Clinical correlates of serum insulin-like growth factor-1 in patients with Parkinson's disease, multiple system atrophy and progressive supranuclear palsy.
    Numao A; Suzuki K; Miyamoto M; Miyamoto T; Hirata K
    Parkinsonism Relat Disord; 2014 Feb; 20(2):212-6. PubMed ID: 24280021
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Quantitative assessment of subcortical atrophy and iron content in progressive supranuclear palsy and parkinsonian variant of multiple system atrophy.
    Lee JH; Han YH; Kang BM; Mun CW; Lee SJ; Baik SK
    J Neurol; 2013 Aug; 260(8):2094-101. PubMed ID: 23670309
    [TBL] [Abstract][Full Text] [Related]  

  • 12. In vivo cholinergic basal forebrain atrophy predicts cognitive decline in de novo Parkinson's disease.
    Ray NJ; Bradburn S; Murgatroyd C; Toseeb U; Mir P; Kountouriotis GK; Teipel SJ; Grothe MJ
    Brain; 2018 Jan; 141(1):165-176. PubMed ID: 29228203
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Voxel-based morphometry detects patterns of atrophy that help differentiate progressive supranuclear palsy and Parkinson's disease.
    Price S; Paviour D; Scahill R; Stevens J; Rossor M; Lees A; Fox N
    Neuroimage; 2004 Oct; 23(2):663-9. PubMed ID: 15488416
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Nucleus basalis of Meynert predicts cognition after deep brain stimulation in Parkinson's disease.
    Kübler D; Wellmann SK; Kaminski J; Skowronek C; Schneider GH; Neumann WJ; Ritter K; Kühn A
    Parkinsonism Relat Disord; 2022 Jan; 94():89-95. PubMed ID: 34896929
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Comparative cognitive and neuropsychiatric profiles between Parkinson's disease, multiple system atrophy and progressive supranuclear palsy.
    Santangelo G; Cuoco S; Pellecchia MT; Erro R; Barone P; Picillo M
    J Neurol; 2018 Nov; 265(11):2602-2613. PubMed ID: 30178175
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Cortical thickness, surface area and volume measures in Parkinson's disease, multiple system atrophy and progressive supranuclear palsy.
    Worker A; Blain C; Jarosz J; Chaudhuri KR; Barker GJ; Williams SC; Brown R; Leigh PN; Simmons A
    PLoS One; 2014; 9(12):e114167. PubMed ID: 25463618
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Postural and gait symptoms in de novo Parkinson's disease patients correlate with cholinergic white matter pathology.
    Nazmuddin M; van Dalen JW; Borra RJH; Stormezand GN; van der Horn HJ; van der Zee S; Boertien J; van Laar T
    Parkinsonism Relat Disord; 2021 Dec; 93():43-49. PubMed ID: 34784526
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Magnetic resonance imaging-based volumetry differentiates idiopathic Parkinson's syndrome from multiple system atrophy and progressive supranuclear palsy.
    Schulz JB; Skalej M; Wedekind D; Luft AR; Abele M; Voigt K; Dichgans J; Klockgether T
    Ann Neurol; 1999 Jan; 45(1):65-74. PubMed ID: 9894879
    [TBL] [Abstract][Full Text] [Related]  

  • 19. QEEG Signatures are Associated with Nonmotor Dysfunctions in Parkinson's Disease and Atypical Parkinsonism: An Integrative Analysis.
    Liu H; Huang Z; Deng B; Chang Z; Yang X; Guo X; Yuan F; Yang Q; Wang L; Zou H; Li M; Zhu Z; Jin K; Wang Q
    Aging Dis; 2023 Feb; 14(1):204-218. PubMed ID: 36818554
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Nucleus basalis of Meynert neuronal activity in Parkinson's disease.
    Lee DJ; Milosevic L; Gramer R; Sasikumar S; Al-Ozzi TM; De Vloo P; Dallapiazza RF; Elias GJB; Cohn M; Kalia SK; Hutchison WD; Fasano A; Lozano AM
    J Neurosurg; 2019 Feb; 132(2):574-582. PubMed ID: 30797189
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.